Stefan Verlohren

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. doi request reprint New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia
    Stefan Verlohren
    Department of Obstetrics, Charite University Medicine Berlin, Chariteplatz 1, D 10117 Berlin, Germany
    Hypertension 63:346-52. 2014
  2. doi request reprint The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
    Stefan Verlohren
    Department of Obstetrics, Campus Virchow Clinic, Charite University Medicine, Berlin, Germany
    Am J Obstet Gynecol 206:58.e1-8. 2012
  3. doi request reprint Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia
    Stefan Verlohren
    Department of Obstetrics, Campus Virchow Clinic, Charite University Medicine Berlin, Germany
    Clin Sci (Lond) 122:43-52. 2012
  4. doi request reprint An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
    Stefan Verlohren
    Department of Obstetrics, Campus Virchow Clinic, Charite University Medicine, Berlin, Germany
    Am J Obstet Gynecol 202:161.e1-161.e11. 2010
  5. doi request reprint Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy
    Stefan Verlohren
    HELIOS Klinikum Berlin Buch and Experimental and Clinical Research Center, Berlin, Germany
    Hypertension 56:304-10. 2010
  6. doi request reprint Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study
    Florian Herse
    Medical Faculty of the Charite, Franz Volhard Clinic, HELIOS Klinikum Berlin Buch and Experimental and Clinical Research Center, Berlin, Germany
    Hypertension 53:393-8. 2009
  7. doi request reprint Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders
    Theresa Engels
    Department of Obstetrics, Charite University Medicine, Berlin, Germany
    Hypertens Pregnancy 32:459-73. 2013

Detail Information

Publications7

  1. doi request reprint New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia
    Stefan Verlohren
    Department of Obstetrics, Charite University Medicine Berlin, Chariteplatz 1, D 10117 Berlin, Germany
    Hypertension 63:346-52. 2014
    ..6%/73.1% and 58.2%/95.5%, respectively. The approach to use multiple cutoffs for the early and late gestational phase enhances the diagnostic accuracy of the sFlt-1/PlGF ratio as a diagnostic tool for preeclampsia. ..
  2. doi request reprint The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
    Stefan Verlohren
    Department of Obstetrics, Campus Virchow Clinic, Charite University Medicine, Berlin, Germany
    Am J Obstet Gynecol 206:58.e1-8. 2012
    ..We tested the hypothesis that the sFlt-1/PlGF ratio is able to identify women at risk for imminent delivery. We characterized the sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders...
  3. doi request reprint Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia
    Stefan Verlohren
    Department of Obstetrics, Campus Virchow Clinic, Charite University Medicine Berlin, Germany
    Clin Sci (Lond) 122:43-52. 2012
    ..Furthermore, we review studies with a clinical focus in which the sFlt-1/PlGF ratio has been analysed along with other candidates for routine clinical assessment of pre-eclampsia...
  4. doi request reprint An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
    Stefan Verlohren
    Department of Obstetrics, Campus Virchow Clinic, Charite University Medicine, Berlin, Germany
    Am J Obstet Gynecol 202:161.e1-161.e11. 2010
    ..This study evaluates a newly developed Elecsys (Roche, Penzberg, Germany) assay for sFlt-1 and PIGF and tests the value of the sFlt-1/PIGF ratio in the assessment of PE...
  5. doi request reprint Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy
    Stefan Verlohren
    HELIOS Klinikum Berlin Buch and Experimental and Clinical Research Center, Berlin, Germany
    Hypertension 56:304-10. 2010
    ..Our model allows the study of dysregulated trophoblast invasion and vascular remodeling in vivo to gain important insights into preeclampsia-related mechanisms...
  6. doi request reprint Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study
    Florian Herse
    Medical Faculty of the Charite, Franz Volhard Clinic, HELIOS Klinikum Berlin Buch and Experimental and Clinical Research Center, Berlin, Germany
    Hypertension 53:393-8. 2009
    ..AT1-AA may represent a better marker for late disease, whereas sFlt1 is a better marker for early onset disease...
  7. doi request reprint Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders
    Theresa Engels
    Department of Obstetrics, Charite University Medicine, Berlin, Germany
    Hypertens Pregnancy 32:459-73. 2013
    ..Our study's aim was to evaluate the use of automated measurement of sFlt1, PlGF and their ratio (sFlt1/PlGF) in differential diagnosis of hypertensive pregnancy disorders...